| Endoscopic application of ankaferd blood stopper as a novel experimental treatment modality for upper gastrointestinal bleeding: a case report M Kurt, S Disibeyaz, M Akdogan, N Sasmaz, S Aksu, IC Haznedaroglu Official journal of the American College of Gastroenterology| ACG 103 (8 …, 2008 | 128 | 2008 |
| Hemostatic efficacy of Ankaferd Blood Stopper® in a swine bleeding model H Bilgili, A Kosar, M Kurt, IK Onal, H Goker, O Captug, A Shorbagi, ... Medical Principles and Practice 18 (3), 165-169, 2009 | 127 | 2009 |
| Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: A retrospective analysis M Kurt, M Akdogan, IK Onal, M Kekilli, M Arhan, A Shorbagi, S Aksu, ... Digestive and Liver Disease 42 (3), 196-199, 2010 | 109 | 2010 |
| In vitro anti-bacterial activities of Ankaferd medicinal plant extract N Akkoc, M Akcelik, IC Haznedaroglu, H Goker, M Turgut, S Aksu, ... Turkiye Klinikleri Tip Bilimleri Dergisi 29 (2), 410-415, 2009 | 83 | 2009 |
| Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia. Y Beyazit, S Aksu, IC Haznedaroglu, M Kekilli, M Misirlioglu, S Tuncer, ... Journal of the National Medical Association 99 (1), 57, 2007 | 65 | 2007 |
| In vitro anti-bacterial activities of Ankaferd blood stopper N Akkoc, M Akceik, I Haznedaroglu, H Goker, S Aksu, S Kirazli, H Firat International Journal of Laboratory Hematology 30, 2008 | 56 | 2008 |
| Discovering blood donor arrival patterns using data mining: A method to investigate service quality at blood centers MC Testik, BY Ozkaya, S Aksu, OI Ozcebe Journal of medical systems 36, 579-594, 2012 | 50 | 2012 |
| Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML S Aksu, Y Beyazit, IC Haznedaroglu, H Canpinar, M Kekilli, A Uner, ... Leukemia & lymphoma 47 (5), 891-896, 2006 | 50 | 2006 |
| EUTOS CML prognostic scoring system predicts ELN-based ‘event-free survival’better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate B Uz, Y Buyukasik, H Atay, E Kelkitli, M Turgut, O Bektas, E Eliacik, A Isik, ... Hematology 18 (5), 247-252, 2013 | 48 | 2013 |
| Determination of burnout levels of nurses working in stem cell transplantation units in Turkey Y Akkuş, Y Karacan, H Göker, S Aksu Nursing & health sciences 12 (4), 444-449, 2010 | 44 | 2010 |
| Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy S Serefhanoglu, Y Buyukasik, H Goker, N Sayinalp, IC Haznedaroglu, ... Leukemia Research 34 (12), e317-e319, 2010 | 36 | 2010 |
| Local umbilical cord blood renin–angiotensin system H Goker, IC Haznedaroglu, Y Beyazit, S Aksu, S Tuncer, M Misirlioglu, ... Annals of hematology 84, 277-281, 2005 | 32 | 2005 |
| Anti-cancer activity of Ankaferd on human colon cancer (CACO-2) in vitro H Goker, E Kilic, D Cetinkaya, Y Buyukasik, S Aksu, M Turgut, ... Ankaferd: Scientific perspectives and basic-clinical data. Istanbul, Naviga …, 2008 | 31 | 2008 |
| Spontaneous tumor lysis syndrome in a patient with diffuse large B cell lymphoma and Richter syndrome A Tufan, N Unal, E Koca, I Onal, S Aksu, I Haznedaroglu Annals of Hematology 85, 183-184, 2006 | 31 | 2006 |
| Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia S Serefhanoglu, Y Buyukasik, H Emmungil, N Sayinalp, IC Haznedaroglu, ... International Journal of Medical Sciences 8 (1), 30, 2011 | 30 | 2011 |
| The value of early treatment in patients with haemophilia and inhibitors K Kavakli, A Yesilipek, B Antmen, S AKSU, C Balkan, D Yilmaz, A Kupesiz, ... Haemophilia 16 (3), 487-494, 2010 | 30 | 2010 |
| Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines S Turk, UY Malkan, M Ghasemi, H Hocaoglu, D Mutlu, G Gunes, S Aksu, ... SAGE open medicine 5, 2050312116689519, 2017 | 29 | 2017 |
| Spinal myeloid sarcoma in two non-leukemic patients S Serefhanoglu, H Goker, S Aksu, Y Buyukasik, N Sayinalp, ... Internal Medicine 49 (22), 2493-2497, 2010 | 28 | 2010 |
| Hyper-CVAD regimen in routine management of adult acute lymphoblastic leukemia: a retrospective multicenter study Y Buyukasik, K Acar, E Kelkitli, B Uz, S Serefhanoglu, E Ozdemir, ... Acta haematologica 130 (3), 199-205, 2013 | 27 | 2013 |
| Effects of imatinib mesylate on renin–angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia M Sayitoglu, IC Haznedaroğlu, O Hatirnaz, Y Erbilgin, S Aksu, E Koca, ... Journal of international medical research 37 (4), 1018-1028, 2009 | 25 | 2009 |
